- Home
- CRON
as 11-15-2024 4:00pm EST
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
| Founded: | 2012 | Country: | Canada |
| Employees: | N/A | City: | STAYNER |
| Market Cap: | 804.7M | IPO Year: | N/A |
| Target Price: | $3.00 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.85 - $3.14 | Next Earning Date: | 11-12-2024 |
| Revenue: | $111,229,000 | Revenue Growth: | 30.31% |
| Revenue Growth (this year): | 29.92% | Revenue Growth (next year): | 16.92% |
Latest Cronos Group Inc. Common Share News
CRON Breaking Stock News: Dive into CRON Ticker-Specific Updates for Smart Investing
GuruFocus.com
4 days ago
Cronos Group Inc (CRON) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic ...
Morningstar Research
4 days ago
Analyst Report: Cronos Group Inc.
Motley Fool
5 days ago
Why Cronos Group Stock Popped 9% Today
Motley Fool
5 days ago
Cronos Group (CRON) Q3 2024 Earnings Call Transcript
Associated Press Finance
5 days ago
Cronos: Q3 Earnings Snapshot
MT Newswires
5 days ago
Cronos Group Up 7.6% In US Premarket as Swings to Q3 Profit
GlobeNewswire
5 days ago
Cronos Group Reports 2024 Third Quarter Results
GuruFocus.com
6 days ago
Cronos Group Inc (TSX:CRON) Q3 2024: Everything You Need To Know Ahead Of Earnings
Compare CRON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRON Cronos Group Inc. Common Share - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.